BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 16410730)

  • 1. Fbxo7 gets proactive with cyclin D/cdk6.
    Laman H
    Cell Cycle; 2006 Feb; 5(3):279-82. PubMed ID: 16410730
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transforming activity of Fbxo7 is mediated specifically through regulation of cyclin D/cdk6.
    Laman H; Funes JM; Ye H; Henderson S; Galinanes-Garcia L; Hara E; Knowles P; McDonald N; Boshoff C
    EMBO J; 2005 Sep; 24(17):3104-16. PubMed ID: 16096642
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Knockdown of Fbxo7 reveals its regulatory role in proliferation and differentiation of haematopoietic precursor cells.
    Meziane el K; Randle SJ; Nelson DE; Lomonosov M; Laman H
    J Cell Sci; 2011 Jul; 124(Pt 13):2175-86. PubMed ID: 21652635
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beyond ubiquitination: the atypical functions of Fbxo7 and other F-box proteins.
    Nelson DE; Randle SJ; Laman H
    Open Biol; 2013 Oct; 3(10):130131. PubMed ID: 24107298
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fbxo7 promotes Cdk6 activity to inhibit PFKP and glycolysis in T cells.
    Harris R; Yang M; Schmidt C; Royet C; Singh S; Natarajan A; Morris M; Frezza C; Laman H
    J Cell Biol; 2022 Jul; 221(7):. PubMed ID: 35670764
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Opposing effects on the cell cycle of T lymphocytes by Fbxo7 via Cdk6 and p27.
    Patel SP; Randle SJ; Gibbs S; Cooke A; Laman H
    Cell Mol Life Sci; 2017 Apr; 74(8):1553-1566. PubMed ID: 27915416
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The characteristics of FBXO7 and its role in human diseases.
    Zhong Y; Li J; Ye M; Jin X
    Gene; 2023 Jan; 851():146972. PubMed ID: 36261086
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SCF(Fbx4/alphaB-crystallin) E3 ligase: when one is not enough.
    Barbash O; Diehl JA
    Cell Cycle; 2008 Oct; 7(19):2983-6. PubMed ID: 18818515
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The E3 Ubiquitin Ligase SCF(Cyclin F) Transmits AKT Signaling to the Cell-Cycle Machinery.
    Choudhury R; Bonacci T; Wang X; Truong A; Arceci A; Zhang Y; Mills CA; Kernan JL; Liu P; Emanuele MJ
    Cell Rep; 2017 Sep; 20(13):3212-3222. PubMed ID: 28954236
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The F-box protein FBXO7 positively regulates bone morphogenetic protein-mediated signaling through Lys-63-specific ubiquitination of neurotrophin receptor-interacting MAGE (NRAGE).
    Kang J; Chung KC
    Cell Mol Life Sci; 2015 Jan; 72(1):181-95. PubMed ID: 24947323
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyclin D degradation by E3 ligases in cancer progression and treatment.
    Qie S; Diehl JA
    Semin Cancer Biol; 2020 Dec; 67(Pt 2):159-170. PubMed ID: 32006569
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Linking F-box protein 7 and parkin to neuronal degeneration in Parkinson's disease (PD).
    Zhou ZD; Sathiyamoorthy S; Angeles DC; Tan EK
    Mol Brain; 2016 Apr; 9():41. PubMed ID: 27090516
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclins and CDKS in development and cancer: lessons from genetically modified mice.
    Santamaria D; Ortega S
    Front Biosci; 2006 Jan; 11():1164-88. PubMed ID: 16146805
    [TBL] [Abstract][Full Text] [Related]  

  • 14. E3 ligase adaptor FBXO7 contributes to ubiquitination and proteasomal degradation of SIRT7 and promotes cell death in response to hydrogen peroxide.
    Lee SH; Lee YJ; Jung S; Chung KC
    J Biol Chem; 2023 Mar; 299(3):102909. PubMed ID: 36646384
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutations in Fbx4 inhibit dimerization of the SCF(Fbx4) ligase and contribute to cyclin D1 overexpression in human cancer.
    Barbash O; Zamfirova P; Lin DI; Chen X; Yang K; Nakagawa H; Lu F; Rustgi AK; Diehl JA
    Cancer Cell; 2008 Jul; 14(1):68-78. PubMed ID: 18598945
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SCF(Fbxw7/hCdc4) targets cyclin E2 for ubiquitin-dependent proteolysis.
    Klotz K; Cepeda D; Tan Y; Sun D; Sangfelt O; Spruck C
    Exp Cell Res; 2009 Jul; 315(11):1832-9. PubMed ID: 19084516
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The F-box protein Fbxo7 interacts with human inhibitor of apoptosis protein cIAP1 and promotes cIAP1 ubiquitination.
    Chang YF; Cheng CM; Chang LK; Jong YJ; Yuo CY
    Biochem Biophys Res Commun; 2006 Apr; 342(4):1022-6. PubMed ID: 16510124
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulating Fbw7 on the road to cancer.
    Xu W; Taranets L; Popov N
    Semin Cancer Biol; 2016 Feb; 36():62-70. PubMed ID: 26459133
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Control of G1 progression by D-type cyclins: key event for cell proliferation.
    Kato JY
    Leukemia; 1997 Apr; 11 Suppl 3():347-51. PubMed ID: 9209386
    [TBL] [Abstract][Full Text] [Related]  

  • 20. F-box protein 7 mutations promote protein aggregation in mitochondria and inhibit mitophagy.
    Zhou ZD; Xie SP; Sathiyamoorthy S; Saw WT; Sing TY; Ng SH; Chua HP; Tang AM; Shaffra F; Li Z; Wang H; Ho PG; Lai MK; Angeles DC; Lim TM; Tan EK
    Hum Mol Genet; 2015 Nov; 24(22):6314-30. PubMed ID: 26310625
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.